Extraction and activity of chymotrypsin using AOT-DOLPA mixed reversed micellar systems

Masahiro Goto, Yoshio Ishikawa, Tsutomu Ono, Fumiyuki Nakashio, T. Alan Hatton

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Novel reversed micellar solutions formulated with a mixture of AOT (dioctyl sulfosuccinate) and DOLPA (dioleyl phosphoric acid) show good potential for use in reversed micellar protein extraction operations. Chymotrypsin is easily extracted from an aqueous phase into organic isooctane containing 10 mM AOT and DOLPA in a 4:1 ratio. The extraction ability of the mixed reversed micelles of 10 mM was higher than that of 200 mM AOT alone. The results of extraction indicated that the AOT-DOLPA mixed reversed micelles are very useful for separating and enriching chymotrypsin. Back-extraction of chymotrypsin from the organic phase to a fresh aqueous phase is also accomplished by adding an alcohol to the organic phase. Although the backtransfer of chymotrypsin from the reversed micelles formed by AOT alone is very slow and difficult, in the AOT-DOLPA mixed reversed micelles, the back-extraction can be achieved completely by addition of 10% (v/v) isobutyl alcohol to the reversed micellar phase. The time to attain to the equilibrium of back-extraction was reduced from more than 24 to 2 h by adding the alcohol. On the basis of the activity data, the best composition of AOT and DOLPA was a 4:1 ratio and the total surfactant concentration was 10 mM. The activity of chymotrypsin recovered from the mixed reversed micelles was higher than that of the initial protein before the forward-transfer. This result means that the novel mixed reversed micellar solutions are useful not only in separation but also in purification of proteins.

Original languageEnglish
Pages (from-to)729-734
Number of pages6
JournalBiotechnology Progress
Volume14
Issue number5
DOIs
Publication statusPublished - Sep 1998
Externally publishedYes

Fingerprint

phosphoric acid
Chymotrypsin
Micelles
chymotrypsin
micelles
alcohols
Dioctyl Sulfosuccinic Acid
Alcohols
Proteins
proteins
Surface-Active Agents
surfactants
dioleoyl phosphate
water

ASJC Scopus subject areas

  • Food Science
  • Biotechnology
  • Microbiology

Cite this

Extraction and activity of chymotrypsin using AOT-DOLPA mixed reversed micellar systems. / Goto, Masahiro; Ishikawa, Yoshio; Ono, Tsutomu; Nakashio, Fumiyuki; Alan Hatton, T.

In: Biotechnology Progress, Vol. 14, No. 5, 09.1998, p. 729-734.

Research output: Contribution to journalArticle

Goto, Masahiro ; Ishikawa, Yoshio ; Ono, Tsutomu ; Nakashio, Fumiyuki ; Alan Hatton, T. / Extraction and activity of chymotrypsin using AOT-DOLPA mixed reversed micellar systems. In: Biotechnology Progress. 1998 ; Vol. 14, No. 5. pp. 729-734.
@article{d26e090529da4daa889dfe009b93b353,
title = "Extraction and activity of chymotrypsin using AOT-DOLPA mixed reversed micellar systems",
abstract = "Novel reversed micellar solutions formulated with a mixture of AOT (dioctyl sulfosuccinate) and DOLPA (dioleyl phosphoric acid) show good potential for use in reversed micellar protein extraction operations. Chymotrypsin is easily extracted from an aqueous phase into organic isooctane containing 10 mM AOT and DOLPA in a 4:1 ratio. The extraction ability of the mixed reversed micelles of 10 mM was higher than that of 200 mM AOT alone. The results of extraction indicated that the AOT-DOLPA mixed reversed micelles are very useful for separating and enriching chymotrypsin. Back-extraction of chymotrypsin from the organic phase to a fresh aqueous phase is also accomplished by adding an alcohol to the organic phase. Although the backtransfer of chymotrypsin from the reversed micelles formed by AOT alone is very slow and difficult, in the AOT-DOLPA mixed reversed micelles, the back-extraction can be achieved completely by addition of 10{\%} (v/v) isobutyl alcohol to the reversed micellar phase. The time to attain to the equilibrium of back-extraction was reduced from more than 24 to 2 h by adding the alcohol. On the basis of the activity data, the best composition of AOT and DOLPA was a 4:1 ratio and the total surfactant concentration was 10 mM. The activity of chymotrypsin recovered from the mixed reversed micelles was higher than that of the initial protein before the forward-transfer. This result means that the novel mixed reversed micellar solutions are useful not only in separation but also in purification of proteins.",
author = "Masahiro Goto and Yoshio Ishikawa and Tsutomu Ono and Fumiyuki Nakashio and {Alan Hatton}, T.",
year = "1998",
month = "9",
doi = "10.1021/bp9800790",
language = "English",
volume = "14",
pages = "729--734",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Extraction and activity of chymotrypsin using AOT-DOLPA mixed reversed micellar systems

AU - Goto, Masahiro

AU - Ishikawa, Yoshio

AU - Ono, Tsutomu

AU - Nakashio, Fumiyuki

AU - Alan Hatton, T.

PY - 1998/9

Y1 - 1998/9

N2 - Novel reversed micellar solutions formulated with a mixture of AOT (dioctyl sulfosuccinate) and DOLPA (dioleyl phosphoric acid) show good potential for use in reversed micellar protein extraction operations. Chymotrypsin is easily extracted from an aqueous phase into organic isooctane containing 10 mM AOT and DOLPA in a 4:1 ratio. The extraction ability of the mixed reversed micelles of 10 mM was higher than that of 200 mM AOT alone. The results of extraction indicated that the AOT-DOLPA mixed reversed micelles are very useful for separating and enriching chymotrypsin. Back-extraction of chymotrypsin from the organic phase to a fresh aqueous phase is also accomplished by adding an alcohol to the organic phase. Although the backtransfer of chymotrypsin from the reversed micelles formed by AOT alone is very slow and difficult, in the AOT-DOLPA mixed reversed micelles, the back-extraction can be achieved completely by addition of 10% (v/v) isobutyl alcohol to the reversed micellar phase. The time to attain to the equilibrium of back-extraction was reduced from more than 24 to 2 h by adding the alcohol. On the basis of the activity data, the best composition of AOT and DOLPA was a 4:1 ratio and the total surfactant concentration was 10 mM. The activity of chymotrypsin recovered from the mixed reversed micelles was higher than that of the initial protein before the forward-transfer. This result means that the novel mixed reversed micellar solutions are useful not only in separation but also in purification of proteins.

AB - Novel reversed micellar solutions formulated with a mixture of AOT (dioctyl sulfosuccinate) and DOLPA (dioleyl phosphoric acid) show good potential for use in reversed micellar protein extraction operations. Chymotrypsin is easily extracted from an aqueous phase into organic isooctane containing 10 mM AOT and DOLPA in a 4:1 ratio. The extraction ability of the mixed reversed micelles of 10 mM was higher than that of 200 mM AOT alone. The results of extraction indicated that the AOT-DOLPA mixed reversed micelles are very useful for separating and enriching chymotrypsin. Back-extraction of chymotrypsin from the organic phase to a fresh aqueous phase is also accomplished by adding an alcohol to the organic phase. Although the backtransfer of chymotrypsin from the reversed micelles formed by AOT alone is very slow and difficult, in the AOT-DOLPA mixed reversed micelles, the back-extraction can be achieved completely by addition of 10% (v/v) isobutyl alcohol to the reversed micellar phase. The time to attain to the equilibrium of back-extraction was reduced from more than 24 to 2 h by adding the alcohol. On the basis of the activity data, the best composition of AOT and DOLPA was a 4:1 ratio and the total surfactant concentration was 10 mM. The activity of chymotrypsin recovered from the mixed reversed micelles was higher than that of the initial protein before the forward-transfer. This result means that the novel mixed reversed micellar solutions are useful not only in separation but also in purification of proteins.

UR - http://www.scopus.com/inward/record.url?scp=0032170757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032170757&partnerID=8YFLogxK

U2 - 10.1021/bp9800790

DO - 10.1021/bp9800790

M3 - Article

C2 - 9758662

AN - SCOPUS:0032170757

VL - 14

SP - 729

EP - 734

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 5

ER -